Skip to main content
Fig. 8 | Cancer Cell International

Fig. 8

From: Signature construction and molecular subtype identification based on liver-specific genes for prediction of prognosis, immune activity, and anti-cancer drug sensitivity in hepatocellular carcinoma

Fig. 8

Dysregulations of ADH4, PON1, PZP, and NR0B1 in HCC at protein level. A–C ADH4, PON1, PZP were lower expressed in HCC tissues than their paired normal liver controls. D NR0B1 positive expression was higher in HCC tissues than their paired normal liver controls. E–G Spearman correlations of ADH4, PON1, PZP, and NR0B1 with MKI67 expression in HCC samples. I–L Comparisons of ADH4, PON1, PZP, and NR0B1 expressions between HCC samples with and without microvascular invasion. Wilcoxon test, Spearman correlation analysis, and Char-square test were used and p < 0.05 was considered significant

Back to article page